Implementing an audit and feedback cycle to improve adherence to the Choosing Wisely Canada recommendations: clustered randomized trail

Table 2 Decrease in prescribing rate by medication type prior to A&F (2014/15), during (2016/17) and post-A&F (2018/19)

Time period	MaPCReN providers N = 178	Control N = 58	Group 1 N = 71	Group 2: N = 49	P-value
Time period	MaPCReN providers N = 178	Control N = 58	Group 1 N = 71	Group 2: N = 49	Control vs Group 1	Control vs Group 2	Group 1 vs Group 2
Number of providers with a decrease in antibiotic or antipsychotic prescribing rate ≥ 1 (n, % of providers)
2014/15 vs 2016/17	157/178 (88.2%)	45/58 (77.6%)	65/71 (91.5%)	47/49 (95.9%)	0.0026	0.0065	0.3456
2014/15 vs 2018/19^a	117/128 (91.4%)	41/47 (87.2%)	55/59 (93.2%)	21/22 (95.5%)	0.2949	0.2919	0.7102
Number of providers with a decrease in antibiotic prescribing rate by ≥ 1 (n, % of providers)
2014/15 vs 2016/17	115/178 (64.6%)	35/58 (60.3%)	49/71 (69.0%)	31/49 (63.3%)	0.127	0.8437	0.2058
2014/15 vs 2018/19^a	100/128 (78.1%)	35/47 (74.5%)	48/59 (81.4%)	17/22 (77.3%)	0.894	0.9141	0.1918
Number of providers with a decrease in antipsychotic prescribing rate by ≥ 1 (n, % of providers)
2014/15 vs 2016/17	105/178 (59.0%)	25/58 (32.6%)	43/71 (60.6%)	37/49 (75.5%)	0.0482	0.0007	0.0878
2014/15 vs 2018/19^a	70/128 (54.7%)	22/47 (36.7%)	33/59 (46.1%)	15/22 (68.2%)	0.3503	0.0971	0.3183

Bolding indicates the p-value was statistically significant
Group 1: Background information
Group 2: Modified report
^aProviders at a clinic that changed EMR vender were not included in the 2018/19 results

ISSN: 2731-4553